TrialJournal for immunotherapy of cancer2025

Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights.

Xuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.